Citations

Clear

114 citation(s) found for "Maria, Lapid".

A feasibility study of virtual group therapy to improve quality of life of cancer caregivers
Lapid, Maria I. , Atherton, Pamela J., Kung, Simon , Clark, Matthew M. , Sloan, Jeff A. , Whitford, Kevin J. , Gentry, Melanie T. , Miller, Janis J., Rummans, Teresa A. , Hubbard, Joleen M. , Gentry, Melanie T , Lapid, Maria I. , Atherton, Pamela J.

Mayo Clinic

Journal of Psychosocial Oncology | November 29, 2021 | Volume: 40 | Issue: 6 | Pages: 854-867

10.1080/07347332.2021.2000550 | PMID 34842060 Get It

Palliative Care: Critical Concepts for the Geropsychiatrist
Lindsey, Jaclyn M. , Shelton, K. Maureen, Beito, Allison H., Lapid, Maria I.

Mayo Clinic

Focus | August 18, 2021 | Volume: 19 | Issue: 3 | Pages: 311-319

10.1176/appi.focus.20210005 | PMID 34690598 Get It

Death and dying are not dirty words: palliative care and the older person in the COVID‐19 pandemic
Lapid, Maria I. , Peisah, Carmelle , Lapid, Maria I.

Mayo Clinic

Psychogeriatrics | July 14, 2021 | Volume: 21 | Issue: 5 | Pages: 844-845

10.1111/psyg.12746 | PMID 34261188 Get It

Emotional Resilience of Older Adults during COVID-19: A Systematic Review of Studies of Stress and Well-Being
Sterina, Evelina , Hermida, Adriana P., Gerberi, Dana , Lapid, Maria I. , Gerberi, Danielle J , Lapid, Maria I.

Mayo Clinic

Clinical Gerontologist | June 3, 2021 | Volume: 45 | Issue: 1 | Pages: 4-19

10.1080/07317115.2021.1928355 | PMID 34080527 Get It

Brain volumetric deficits in MAPT mutation carriers: a multisite study
Chu, Stephanie A. , Flagan, Taru , Staffaroni, Adam M. , Jiskoot, Lize C. , Deng, Jersey, Sturm, Virginia E. , Yokoyama, Jennifer S. , Papma, Janne M. , Geschwind, Dan, Rosen, Howard J. , Boxer, Adam L. , Heuer, Hilary W. , Forsberg, Leah K. , Brushaber, Danielle , Coppola, Giovanni , Bordelon, Yvette , Faber, Kelley , Feldman, Howard , Fields, Julie A. , Gavrilova, Ralitza H. , Ghoshal, Nupur , Graff‐Radford, Neill R. , Hsiung, Ging‐Yuek Robin , Huey, Edward D. , Kantarci, Kejal , Kaufer, Daniel , Karydas, Anna M., Kornak, John , Kramer, Joel H. , Kukull, Walter A. , Mackenzie, Ian R. , Mendez, Mario F. , Miller, Bruce L. , Onyike, Chiadi U. , Pantelyat, Alexander , Rademakers, Rosa , Ramos, Eliana Marisa , Roberson, Erik D. , Tartaglia, Maria Carmela , Tatton, Nadine , Toga, Arthur W. , Vetor, Ashley, Weıntraub, Sandra , Wong, Bonnie , Lee, Suzee E. , Brushaber, Danielle E, Kantarci, Kejal , Knopman, David S. , Lee, Suzee E , Hsiung, Gink-Yuek , Roberson, Erik , Miller, Bruce L , Pantelyat, Alex , Tartaglia, Maria Carmela , Yokoyama, Jennifer , Feldman, Howard H , Jiskoot, Lize C , Spina, Salvatore , Zhang, Liwen , Seeley, William W. , Boeve, Bradley F. , Grossman, Murray , Dickerson, Bradford Clark , Fong, Jamie , Foroud, Tatiana , Irwin, David J. , Knopman, David S. , Lapid, Maria I. , Litvan, Irene , Wszołek, Zbigniew K. , Swieten, John C. van

Mayo Clinic

Annals of Clinical and Translational Neurology | November 28, 2020 | Volume: 8 | Issue: 1 | Pages: 95-110

10.1002/acn3.51249 | PMID 33247623 Get It

AbstractObjectiveMAPT mutations typically cause behavioral variant frontotemporal dementia with or without parkinsonism. Previous studies have shown that symptomatic MAPT mutation carriers have frontotemporal atrophy, yet studies have shown mixed results as to whether presymptomatic carriers have low gray matter volumes. To elucidate whether presymptomatic carriers have lower structural brain volumes within regions atrophied during the symptomatic phase, we studied a large cohort of MAPT mutation carriers using a voxelwise approach.MethodsWe studied 22 symptomatic carriers (age 54.7 ± 9.1, 13 female) and 43 presymptomatic carriers (age 39.2 ± 10.4, 21 female). Symptomatic carriers’ clinical syndromes included: behavioral variant frontotemporal dementia (18), an amnestic dementia syndrome (2), Parkinson’s disease (1), and mild cognitive impairment (1). We performed voxel‐based morphometry on T1 images and assessed brain volumetrics by clinical subgroup, age, and mutation subtype.ResultsSymptomatic carriers showed gray matter atrophy in bilateral frontotemporal cortex, insula, and striatum, and white matter atrophy in bilateral corpus callosum and uncinate fasciculus. Approximately 20% of presymptomatic carriers had low gray matter volumes in bilateral hippocampus, amygdala, and lateral temporal cortex. Within these regions, low gray matter volumes emerged in a subset of presymptomatic carriers as early as their thirties. Low white matter volumes arose infrequently among presymptomatic carriers.InterpretationA subset of presymptomatic MAPT mutation carriers showed low volumes in mesial temporal lobe, the region ubiquitously atrophied in all symptomatic carriers. With each decade of age, an increasing percentage of presymptomatic carriers showed low mesial temporal volume, suggestive of early neurodegeneration.
Impact of Massage Therapy on the Quality of Life of Hospice Patients and Their Caregivers: A Pilot Study
Havyer, Rachel D. , Dockter, Travis , McCue, Shaylene , Stelpflug, Amy J., Bigelow, Maureen L., Robsahm, Mary Meg, Elwood, Theresa, Strand, Jacob J. , Bauer, Brent A. , Cutshall, Susanne M. , Sloan, Jeff A. , Walton, Monica P., Whitford, Kevin J. , Dockter, Travis J, Lapid, Maria I.

Mayo Clinic

Journal of Palliative Care | November 20, 2020 | Volume: 37 | Issue: 1 | Pages: 41-47

10.1177/0825859720975991 | PMID 33213233 Get It

Evidence for massage therapy (MT) in hospice patients remains limited. We conducted a prospective pilot study on MTs impact on quality of life of hospice patients and caregivers. Patient-caregiver dyads were enrolled if patients scored ≥5 on pain, depression, anxiety, or well-being using the revised Edmonton Symptom Assessment System Revised (ESAS-r). The patient received MT weekly for up to 3 massages with assessments completed at baseline, after each massage, and 1 week after the final massage for patients and at baseline and 1 week after final massage for caregivers. A satisfaction survey was completed at study completion. A pro-rated area under the curve (AUC) was utilized to assess the primary endpoints of change in ESAS-r for patient ratings of pain, depression and anxiety as well as the Linear Analogue Self-Assessment (LASA). Median difference scores (end of study value)-(baseline value) for each participant and caregiver were calculated. Of 27 patients and caregivers enrolled, 25 patients received MT. Fifteen patients completed all 3 MT sessions and were given the final symptom assessment and satisfaction survey and their caregivers completed final assessments. The proportion of patients considered success (AUC > baseline) in the primary endpoints were the following: pain 40.9%, depression 40.9%, anxiety 54.5%, LASA 54.5%. Median difference scores were largely zero indicating no significant temporal change in symptoms. Patients were highly satisfied with MT. This pilot study indicated that MT was a feasible and well-received intervention in our population of patients with inadequately controlled symptoms.
Reconnecting: Strategies for Supporting Isolated Older Adults during COVID-19 through Tele-palliative Care
Mackey, Regina M. , Yeow, Mei Ean, Christensen, April , Ingram, Cory , Carey, Elise C. , Lapid, Maria I. , Yeow, Mei E, Christensen, April R, Lapid, Maria I. , Christensen, April R , Yeow, Mei-Ean

Mayo Clinic

Clinical Gerontologist | October 19, 2020 | Volume: 45 | Issue: 1 | Pages: 204-211

10.1080/07317115.2020.1830905 | PMID 33074777 Get It

Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort
Gentry, Melanie T. , Syrjanen, Jeremy A. , Calvert, Kendrick J., Hughes, Samantha R., Brushaber, Danielle , Kremers, Walter K. , Bove, Jessica, Brannelly, Patrick , Coppola, Giovanni , Dheel, Christina, Dickinson, Susan, Faber, Kelley, Fields, Julie A. , Forsberg, Leah K. , Gavrilova, Ralitza H. , Gearhart, Deb, Ghoshal, Nupur , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Haley, Dana , Heuer, Hilary W. , Hsiung, Ging‐Yuek Robin , Huey, Edward D. , Irwin, David J. , Jones, Lynne C. , Kantarci, Kejal , Karydas, Anna, Kornak, John , Kramer, Joel H. , Kukull, Walter A. , Lucente, Diane , Lungu, Codrin , Mackenzie, Ian R. , Manoochehri, Masood , McGinnis, Scott, Miller, Bruce L. , Pearlman, Rodney , Petrucelli, Len, Potter, Madeline, Rademakers, Rosa , Ramos, Eliana Marisa , Rankin, Katherine P. , Rascovsky, Katya, Sengdy, Pheth, Shaw, Leslie M. , Tatton, Nadine , Taylor, Joanne, Trojanowski, John Q. , Weıntraub, Sandra , Wong, Bonnie , Boxer, Adam L. , Rosen, Howard J. , Calvert, Kendrick, Hughes, Samantha, Irwin, David J , Hsiung, Gink-Yuek , Miller, Bruce L , Kantarci, Kejal , Gentry, Melanie T , Kremers, Walter K , Lapid, Maria I. , Dickerson, Bradley, Fong, Jamie , Foroud, Tatiana , Gearhart, Deb, Goldman, Jill , Grossman, Murray , Jones, David T. , Jones, Lynne, Knopman, David S. , Toga, Arthur W. , Wszołek, Zbigniew K. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | July 13, 2020 | Volume: 16 | Issue: 8 | Pages: 1115-1124

10.1002/alz.12095 | PMID 32656921 Get It

AbstractObjectiveThe Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects evaluates familial frontotemporal lobar degeneration (FTLD) kindreds with MAPT, GRN, or C9orf72 mutations. Objectives were to examine whether health‐related quality of life (HRQoL) correlates with clinical symptoms and caregiver burden, and whether self‐rated and informant‐rated HRQoL would correlate with each other.MethodsIndividuals were classified using the Clinical Dementia Rating (CDR®) Scale plus National Alzheimer's Coordinating Center (NACC) FTLD. HRQoL was measured with DEMQOL and DEMQOL‐proxy; caregiver burden with the Zarit Burden Interview (ZBI). For analysis, Pearson correlations and weighted kappa statistics were calculated.ResultsThe cohort of 312 individuals included symptomatic and asymptomatic individuals. CDR® plus NACC FTLD was negatively correlated with DEMQOL (r = −0.20, P = .001), as were ZBI and DEMQOL (r = −0.22, P = .0009). There was fair agreement between subject and informant DEMQOL (κ = 0.36, P <.0001).ConclusionLower HRQoL was associated with higher cognitive/behavior impairment and higher caregiver burden. These findings demonstrate the negative impact of FTLD on individuals and caregivers.
Hearing and Heeding the Voices of those With Advanced Illnesses
Piderman, Katherine M. , Breitkopf, Carmen Radecki , Jenkins, Sarah M. , Ingram, Cory , Sytsma, Terin T. , Tata, Beba , Chatterjee, Krishanu , Egginton, Jason S. , Jatoi, Aminah , Tata, Beba S, Lapid, Maria I.

Mayo Clinic

Journal of Palliative Care | May 29, 2020 | Volume: 35 | Issue: 4 | Pages: 248-255

10.1177/0825859720928623 | PMID 32466734 Get It

Objectives: To describe the feasibility of a chaplain-led spiritually focused life review interview and the development of a spiritual legacy document (SLD) for patients with advanced diseases and to describe changes in spiritual well-being (SWB), spiritual coping strategies (SC), and quality of life (QOL) after receiving the SLD. Patients and Methods: In all, 130 patients and support person (SP) pairs were recruited from July 2012 to January 2019. Following enrollment, demographic information was gathered and baseline questionnaires were administered. Functional Assessment of Chronic Illness Therapy–Spiritual Well-Being Scale (FACIT-Sp-12) and a linear analog scale assessment (LASA) measured SWB. LASAs also measured QOL and emotional well-being (EWB). Positive Religious Coping Scale (RCOPE) measured SC. After completion of baseline forms, participants were interviewed (individually) by a chaplain. Interviews were digitally recorded, transcribed, and verified. Transcripts were edited and participants were given the opportunity to make adaptations. The participant-approved draft was then developed into a professionally printed SLD. Follow-up questionnaires were administered to assess change. Results: Significant improvements from baseline to post-SLD follow-up were found for patients on the LASAs: SWB (average 7.7-8.3, P = .01), QOL (average 6.7-7.3, P = .03), EWB (average 6.9-7.5, P = .01), and on the positive RCOPE (average 1.8-2.0, P = .007). Effect sizes were approximately 0.25. Considering any improvement, 61.0% improved their positive RCOPE score, 46.6% improved EWB, and 39.7% improved SWB. No significant changes were found on the FACIT-Sp-12. No significant changes were found for SPs. Conclusion: The results suggest that the primary participants who completed the study benefited by significantly increasing their QOL, SWB, EWB, and SC.
Dementia palliative care in the acute psychiatric hospital: A feasibility study
Gentry, Melanie T. , Clark, Matthew M. , Rummans, Teresa A. , Ryan, Susan M, Gentry, Melanie T , Ryan, Susan , Lapid, Maria I.

Mayo Clinic

Perspectives in Psychiatric Care | January 15, 2020 | Volume: 56 | Issue: 3 | Pages: 593-597

10.1111/ppc.12473 | PMID 31944318 Get It

AbstractPurposeWe explored the feasibility of a clinical pathway to identify hospitalized patients with dementia who would benefit from a palliative intervention.Design and MethodsConsecutive geropsychiatric admissions were screened for terminal dementia to be randomized to a palliative consultation vs usual care.FindingsA total of 43 of the 188 patients (23%) had dementia; however, dementia stages were severe but not terminal. The pathway was not feasible because of the lack of the target population in the inpatient setting for the intervention.Practice ImplicationsNew clinical pathways are needed to identify patients with dementia who would benefit from palliative care.